{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:52:25Z","timestamp":1772671945086,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T00:00:00Z","timestamp":1705795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jsps.2024.101965","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T17:10:49Z","timestamp":1705943449000},"page":"101965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Guideline-directed medical therapy in heart failure patients with reduced ejection fraction in Palestine: Retrospective clinical audit study"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4471-0878","authenticated-orcid":false,"given":"Ammar Abdulrahman","family":"Jairoun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabaa Saleh","family":"Al-Hemyari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8367-4841","authenticated-orcid":false,"given":"Moyad","family":"Shahwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa'ed H.","family":"Zyoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maimona","family":"Jairoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2024.101965_b0005","first-page":"2642","article-title":"Guideline-directed medical therapy in heart failure patients with reduced ejection fraction in Oman: utilization, reasons behind non-prescribing, and dose optimization","volume":"20","author":"Al-Aghbari","year":"2022","journal-title":"Pharm. Pract."},{"key":"10.1016\/j.jsps.2024.101965_b0010","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of hospitalizations for heart failure","volume":"63","author":"Ambrosy","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jsps.2024.101965_b0015","first-page":"1","article-title":"Evaluation of a guideline directed medical therapy titration program in patients with heart failure with reduced ejection fraction","volume":"22","author":"Balakumaran","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jsps.2024.101965_b0020","first-page":"13","article-title":"Contemporary drug treatment of chronic heart failure with reduced ejection fraction. JACC","volume":"7","author":"Brunner-La Rocca","year":"2019","journal-title":"Heart Fail."},{"key":"10.1016\/j.jsps.2024.101965_b0025","doi-asserted-by":"crossref","first-page":"e003529","DOI":"10.1161\/CIRCHEARTFAILURE.116.003529","article-title":"Thirty years of evidence on the efficacy of drug treatments for chronic heart failure with reduced ejection fraction: a network meta-analysis","volume":"10","author":"Burnett","year":"2017","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.jsps.2024.101965_b0030","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jcma.2017.04.011","article-title":"Gap between guidelines and clinical practice in heart failure with reduced ejection fraction: results from TSOC-HFrEF registry","volume":"80","author":"Chang","year":"2017","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.jsps.2024.101965_b0035","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/ejhf.813","article-title":"Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC heart failure long-term registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jsps.2024.101965_b0040","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsps.2024.101965_b0045","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/ehf2.12454","article-title":"Medical therapy doses at hospital discharge in patients with existing and de novo heart failure","volume":"6","author":"Diamant","year":"2019","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.jsps.2024.101965_b0050","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cjca.2017.08.022","article-title":"2017 comprehensive update of the Canadian cardiovascular society guidelines for the management of heart failure","volume":"33","author":"Ezekowitz","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.jsps.2024.101965_b0055","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/ejhf.549","article-title":"Medical resource use and expenditure in patients with chronic heart failure: a population-based analysis of 88 195 patients","volume":"18","author":"Farr\u00e9","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jsps.2024.101965_b0060","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamacardio.2020.0640","article-title":"Assessment of limitations to optimization of guideline-directed medical therapy in heart failure from the GUIDE-IT trial: a secondary analysis of a randomized clinical trial","volume":"5","author":"Fiuzat","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.jsps.2024.101965_b0065","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.109.934471","article-title":"Improving evidence-based care for heart failure in outpatient cardiology practices","volume":"122","author":"Fonarow","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jsps.2024.101965_b0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/xJAHA.111.000018","article-title":"Incremental reduction in risk of death associated with use of guideline-recommended therapies in patients with heart failure: a nested case-control analysis of IMPROVE HF","volume":"1","author":"Fonarow","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.jsps.2024.101965_b0075","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/eurjhf\/hft011","article-title":"Patient adherence to evidence-based pharmacotherapy in systolic heart failure and the transition of follow-up from specialized heart failure outpatient clinics to primary care","volume":"15","author":"Gjesing","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jsps.2024.101965_b0080","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jsps.2024.101965_b0085","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry","volume":"72","author":"Greene","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jsps.2024.101965_b0090","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","volume":"22","author":"Groenewegen","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jsps.2024.101965_b0095","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s11096-020-01190-2","article-title":"Evaluation of guideline-based cardiovascular medications and their respective doses in heart failure patients in Oman","volume":"43","author":"Hanbali","year":"2020","journal-title":"Int. J. Clin. Pharm."},{"key":"10.1016\/j.jsps.2024.101965_b0100","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/ejhf.945","article-title":"A comprehensive population-based characterization of heart failure with mid-range ejection fraction","volume":"19","author":"Koh","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jsps.2024.101965_b0105","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ejhf.510","article-title":"Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey","volume":"18","author":"Komajda","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jsps.2024.101965_b0110","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/ejhf.887","article-title":"Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry","volume":"19","author":"Komajda","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jsps.2024.101965_b0115","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.amjcard.2011.02.322","article-title":"Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from get with the guidelines\u2013heart failure)","volume":"107","author":"Krantz","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jsps.2024.101965_b0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.21037\/amj.2020.03.03","article-title":"Global epidemiology and future trends of heart failure","volume":"5","author":"Lippi","year":"2020","journal-title":"AME Med. J."},{"key":"10.1016\/j.jsps.2024.101965_b0125","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jacc.2020.11.022","article-title":"2021 update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction","volume":"77","author":"Maddox","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jsps.2024.101965_b0130","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/eurjhf\/hft134","article-title":"Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC heart failure long-lerm registry","volume":"15","author":"Maggioni","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jsps.2024.101965_b0135","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ejhf.1351","article-title":"Medication dosing for heart failure with reduced ejection fraction - opportunities and challenges","volume":"21","author":"Marti","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jsps.2024.101965_b0140","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jsps.2024.101965_b0145","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cjca.2021.01.017","article-title":"CCS\/CHFS heart failure guidelines update: defining a new pharmacologic standard of care for heart failure with reduced ejection fraction","volume":"37","author":"McDonald","year":"2021","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.jsps.2024.101965_b0150","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsps.2024.101965_b0155","doi-asserted-by":"crossref","unstructured":"MERIT-HF Study Group, 1999. Effect of metoprolol CR\/XL in chronic heart failure: metoprolol CR\/XL randomised intervention trial in-congestive heart failure (MERIT-HF). Lancet. 353, 2001\u20132007. https:\/\/doi.org\/10.1016\/s0140-6736(99)04440-2.","DOI":"10.1016\/S0140-6736(99)04440-2"},{"key":"10.1016\/j.jsps.2024.101965_b0160","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/eurheartj\/ehx026","article-title":"Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study","volume":"38","author":"Ouwerkerk","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jsps.2024.101965_b0165","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure","volume":"334","author":"Packer","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsps.2024.101965_b0170","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","article-title":"Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jsps.2024.101965_b0175","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsps.2024.101965_b0180","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsps.2024.101965_b0185","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsps.2024.101965_b0190","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijcard.2014.04.255","article-title":"Dose matters! Optimisation of guideline adherence is associated with lower mortality in stable patients with chronic heart failure","volume":"175","author":"Poelzl","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jsps.2024.101965_b0195","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jsps.2024.101965_b0200","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/ehv464","article-title":"Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction","volume":"37","author":"Solomon","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jsps.2024.101965_b0205","doi-asserted-by":"crossref","first-page":"e1008","DOI":"10.1016\/S2214-109X(18)30306-1","article-title":"Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study","volume":"6","author":"Teng","year":"2018","journal-title":"Lancet Glob. Health."},{"key":"10.1016\/j.jsps.2024.101965_b0210","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/ejhf.807","article-title":"Characterization of heart failure patients with mid-range left ventricular ejection fraction\u2014a report from the CHART-2 study","volume":"19","author":"Tsuji","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jsps.2024.101965_b0215","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ejhf.483","article-title":"Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review","volume":"18","author":"van Riet","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jsps.2024.101965_b0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial","volume":"353","author":"Writers","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jsps.2024.101965_b0225","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jacc.2017.11.025","article-title":"2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction","volume":"71","author":"Yancy","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jsps.2024.101965_b0230","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jsps.2024.101965_b0235","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsps.2024.101965_b0240","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/0003319720905742","article-title":"Implementation of guideline-recommended therapies for patients with heart failure and reduced ejection fraction: a regional Arab Middle East experience","volume":"71","author":"Zubaid","year":"2020","journal-title":"Angiology"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S131901642400015X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S131901642400015X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:24:46Z","timestamp":1736184286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S131901642400015X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S131901642400015X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2024.101965","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guideline-directed medical therapy in heart failure patients with reduced ejection fraction in Palestine: Retrospective clinical audit study","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2024.101965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}],"article-number":"101965"}}